Enter your ZIP code:

Please enter a 5 digit zipcode
No results...

Entering your zip code helps us to provide information and results that are more relevant to you.

Your privacy is important to us. By continuing, you agree to our Privacy Policy.

Get Care Now Pay My Bill News Careers Giving Patient Portal
Schedule an Appointment
Home Clinicians Krishnansu S. Tewari, MD
Krishnansu S. Tewari, MD

Krishnansu S. Tewari, MD

Gynecologic Oncology, Obstetrics & Gynecology

4.7 (153)
Schedule an Appointment

Services:

Clinical Interests:

cytoreductive surgery for advanced gynecologic cancers, ovarian carcinoma and other gynecologic cancers, ovarian cancer, fallopian tube and primary peritoneal cancers, gynecologic oncology, gynecologic tumors, da Vinci® robot-assisted surgery

Schedule an Appointment

New Patient Appointment

Select a time and fill in your information to quickly and easily schedule an appointment.

Schedule an Appointment

To schedule a new patient appointment call: 714-456-8000

Schedule an Appointment

If you're a current patient please visit the patient portal or call: 714-456-8000

Go to Patient Portal

Having a medical emergency? Call 911.

Ratings & Reviews

Overall Rating

4.7
4.7 (153)
41 Reviews
5
4
3
2
1
0 (0)
0 (0)

Background

  • Professional Positions

    • Professor and Chief — Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, UC Irvine School of Medicine
    • Member — Chao Family Comprehensive Cancer Center
    • Vice President— Orange County Obstetrics & Gynecology Society

  • Gender

    Male

  • Board Certifications

    American Board of Obstetrics and Gynecology, American Board of Obstetrics and Gynecology

  • Medical Education

    • University of Calif College of Medicine - Irvine|UC Irvine School of Medicine|University of California
    • Irvine

  • Residencies

    • UCI Medical Center - Department of OB/GYN|University of California College of Med
    • Irvine|University of California
    • Irvine

  • Fellowships

    • UCI Medical Center - Department of Gynecological Oncology|UCI College of Medicine|University of California Irvine

  • Awards

    • Physicians of Excellence, Orange County Medical Association — 2012-2023
    • Best Doctors in America® — Obstetrics and Gynecology, 2011-2013, 2015, 2016
    • America's Top Doctors (Cervical Cancer, Ovarian Cancer), Castle Connolly Medical Ltd., 2012
    • 1st Prize Award, International Gynecologic Cancer Society, 2000
    • John Molitor, MD, Volunteer Clinical Faculty Award

  • Languages Spoken

    English

  • Academic Profile

    View this physician's faculty profile

    Speakers Bureau topics

    • Cancer in pregnancy
    • Cervical cancer vaccine development
    • Cervical cancer, advancements in management
    • Endometrial cancer
    • Fertility preservation
    • Gestational trophoblastic disease
    • Gynecologic oncology: Angiogenesis-targeted therapeutics
    • Human papillomavirus: Molecular genetics
    • Ovarian cancer (metastatic): Advancements in management
    • Solid tumor oncology: Biologic-targeted therapeutics
    • Vulva diseases

Current Clinical Trials

Randomized, Multicenter, Open-label, Phase III Study of Mirvetuximab Soravtansine in Combination With Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients With FrA-positive Recurrent Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Who Have Not Progressed After Second Line Platinum-based Chemotherapy Plus Bevacizumab
Age Group: Adults
Principal Investigator: Krishnansu Tewari
Conditions:
Cervix Cancer
Genital Disorders
Reproductive Disorders